HLA-E
-
Official Full Name
major histocompatibility complex, class I, E -
Overview
HLA-E belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. HLA-E binds a restricted subset of peptides derived from the leader peptides of other class I molecules. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. -
Synonyms
HLA-E;major histocompatibility complex, class I, E;HLA class I histocompatibility antigen, alpha chain E;MHC HLA-E alpha-1;lymphocyte antigen;MHC HLA-E alpha-2.1;MHC class I antigen E;HLA class I histocompatibility antigen, E alpha chain;MHC;QA1;EA1.2;EA2.1;HLA-6.2;DKFZp686P19218
Recombinant Proteins
- Human
- E.coli
- HEK293
- Insect Cells
- Mammalian Cells
- In Vitro Cell Free System
- His
- Non
- Avi
- Fc
- Myc
- Flag
- GST
- SUMO
| Cat.# | Product name | Source (Host) | Species | Tag | Protein Length | Price |
|---|---|---|---|---|---|---|
| HLA-E-3399H | Recombinant Human HLA-E protein, His-tagged | E.coli | Human | His | 23-303 aa | |
| HLA-E-1746H | Recombinant Human HLA-E protein, His-tagged | E.coli | Human | His | Gly22~Leu358 |
|
| HLA-E-800HCL | Recombinant Human HLA-E cell lysate | Human | Non |
|
||
| HLA-E-038H | Recombinant Human HLA-E protein, His-Avi-tagged | HEK293 | Human | Avi&His | It contains Gly25-Ile305(HLA-E),Ile21-Met119(B2M) and VMAPRTLVL peptide. |
|
| HLA-E-039H | Recombinant Human HLA-E protein, His-Avi-tagged, Biotinylated | HEK293 | Human | Avi&His | It contains Gly25-Ile305(HLA-E),Ile21-Met119(B2M) and VMAPRTLVL peptide. |
|
| HLA-E-040HP | Recombinant Human HLA-E complex Protein (tetramer), His-Avi-tagged, PE-Labeled | HEK293 | Human | Avi&His | Gly25-Ile305(HLA-E*01:03),Ile21-Met119(B2M) and VMAPRTLVL peptide |
|
| HLA-E-1076H | Recombinant Human HLA-E Protein, His (Fc)-Avi-tagged | HEK293 | Human | Avi&Fc&His |
|
|
| HLA-E-1076H-B | Recombinant Human HLA-E Protein Pre-coupled Magnetic Beads | HEK293 | Human |
|
||
| HLA-E-2276H | Recombinant Human HLA-E protein, His&Myc-tagged | Insect Cells | Human | His&Myc | 22-305aa |
|
| HLA-E-268HFL | Recombinant Full Length Human HLA-E Protein, C-Flag-tagged | Mammalian Cells | Human | Flag | Full L. |
|
| HLA-E-3602HF | Recombinant Full Length Human HLA-E Protein, GST-tagged | In Vitro Cell Free System | Human | GST | Full L. 358 amino acids |
|
| HLA-E-3872H | Recombinant Human HLA-E protein, His-SUMO-tagged | E.coli | Human | His&SUMO | 22-305aa |
|
Involved Pathway
HLA-E involved in several pathways and played different roles in them. We selected most pathways HLA-E participated on our site, such as Endocytosis,Phagosome,Cell adhesion molecules (CAMs), which may be useful for your reference. Also, other proteins which involved in the same pathway with HLA-E were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
| Pathway Name | Pathway Related Protein |
|---|---|
| Phagosome | MPO,COLEC12,HLA-G,ATP6V0C,RILP,DYNC1LI1,TUBA8L3,CTSSB.1,FCGR2B,HLA-C |
| Endocytosis | SNX3,RET,PLD1A,LDLRA,RAB11FIP4,HLA-F,ERBB3,CAPZA1B,RHOAC,EPN2 |
| ne thyroid disease | HLA-DRB4,Ifna15,HLA-F,CD80,Fasl,FAS,HLA-DPA1,TG,HLA-DRB5,TSHB |
| Epstein-Barr virus infection | SYK,HDAC4,PIK3CA,MAP2K4,HLA-DRB4,RBPJL,POLR2K,MAP2K6,EIF2AK3,POLR2F |
| Antigen processing and presentation | TNF,RFXAP,KIR2DS2,HLA-B,KIR2DS4,RFX5,HLA-DPB1,HSPA1L,PSME1,CD4 |
| Viral myocarditis | CCND1,SGCD,FYN,HLA-DRB3,ABL1,HLA-DQA1,LAMA2,CAV1,ITGAL,HLA-DPB1 |
| Cell adhesion molecules (CAMs) | PECAM1,ITGB8,H2-Q10,GLYCAM1,NCAM1,CLDN11B,F11R.1,Siglec1,ITGA4,MHC2A |
| Graft-versus-host disease | H2-Q10,HLA-DPB1,HLA-DQB1,IL1B,HLA-DOB,HLA-DQA1,H2-AA,HLA-DMB,HLA-C,HLA-DRB3 |
| Natural killer cell mediated cytotoxicity | HLA-C,KIR2DS4,IFNGR1,IFNAR1,ARAF,NCR1,IFNA1,HLA-B,IFNA5,PIK3CG |
Protein Function
HLA-E has several biochemical functions, for example, MHC class I protein binding,beta-2-microglobulin binding,natural killer cell lectin-like receptor binding. Some of the functions are cooperated with other proteins, some of the functions could acted by HLA-E itself. We selected most functions HLA-E had, and list some proteins which have the same functions with HLA-E. You can find most of the proteins on our site.
| Function | Related Protein |
|---|---|
| natural killer cell lectin-like receptor binding | Raet1c,RAET1D,CLEC2H,MICA,ULBP2,RAET1G,MICB,ULBP1,CLEC2G,RAET1E |
| beta-2-microglobulin binding | CD1d1,CD1D2,CD1E,HFE,CD1A,HLA-A,FCGRT,CD1B,CD1C,CD1D |
| MHC class I protein binding | Pilrb1,PILRB,TAP1,CD8A,ATP5B,TAPBP,PILRB2,CD8B,VCP,DERL1 |
| peptide antigen binding | BF2,MHC1UDA,MHC1ZHA,MHC1ZBA,HLA-DQB1,CD209,MHC1ZFA,HLA-DRB3,MHC1UEA,MR1 |
| receptor binding | FGF6A,ACOT8,WNT2BB,LTA,APLN,CLCF1,FZD1,APOF,NUDT19,WNT11R |
Interacting Protein
HLA-E has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with HLA-E here. Most of them are supplied by our site. Hope this information will be useful for your research of HLA-E.
YPMT1.25Ac;TRAPPC2;fusA;lldD1;q5ni35_fratt;q7chg5_yerpe;proW;q7ckk6_yerpe;deoB;ptsG;y2173_bacan;q81wx2_bacan;dacF;q81z87_bacan;q8cl08_yerpe;sfcA2;leuB;PPP1R16A
Resources
Research Area
Related Services
Related Products
References
- Cheung, PFY; Yip, CW; et al. Granulin-Epithelin Precursor Renders Hepatocellular Carcinoma Cells Resistant to Natural Killer Cytotoxicity. CANCER IMMUNOLOGY RESEARCH 2:1209-1219(2014).
- Ravindranath, MH; Terasaki, PI; et al. Suppression of blastogenesis and proliferation of activated CD4(+) T cells: intravenous immunoglobulin (IVIg) versus novel anti-human leucocyte antigen (HLA)-E monoclonal antibodies mimicking HLA-I reactivity of IVIg. CLINICAL AND EXPERIMENTAL IMMUNOLOGY 178:154-177(2014).
